000 | 02136cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030735.0 | ||
008 | 130109s2012 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aM.Sc | ||
099 | _aCai01.11.22.M.Sc.2012.Am.R | ||
100 | 0 | _aAmr Mohammed Salah Elhennawy | |
245 | 1 | 0 |
_aRole of ¹⁸F-FDG (fluro-deoxy-glucose) PET/CT in patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative ¹³¹I whole body scan / _cAmr Mohammed Salah Elhennawy ; Supervised Hosna Mohammed Moustafa , Haitham F. Abdulhamid , Khaled Mohammed Taalab |
246 | 1 | 5 | _aدور المسح الذري المقطعي بالإنبعاث البوزيتروني باستعمال الفلوروديؤكسي جلوكوز المشع المدمج مع الأشعة المقطعيه في مرضى سرطان الغدة الدرقيه النوعى في حالات ارتفاع الثيروجلوبيولين و سلبيه المسح الذري باستخدام اليود المشع |
260 |
_aCairo : _bAmr Mohammed Salah Elhennawy , _c2012 |
||
300 |
_a99 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Nuclear Medicine | ||
520 | _aSerum Tg appears to be the most sensitive test in follow up of differentiated cancer thyroid while other imaging methods as ultrasound and CT may be helpful with limited sensitivity. Rising thyroglobulin levels are generally a reliable indicator of recurrent thyroid cancer. This study aimed to detect the ability of 18F-FDG with PET/CT to explain the elevated Tg levels in patients with DCT and negative 131-I WBS | ||
530 | _aIssued also as CD | ||
653 | 4 | _a5-flurouracil | |
653 | 4 | _aDTC | |
653 | 4 | _aPET/CT | |
700 | 0 |
_aHaitham Fouad Abdulhamid , _eSupervisor |
|
700 | 0 |
_aHosna Mohammed Moustafa , _eSupervisor |
|
700 | 0 |
_aKhaled Mohammed Taalab , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c40971 _d40971 |